Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
05 nov. 2020 07h00 HE
|
Amryt Pharma plc
AMRYT REPORTS RECORD Q3 2020 RESULTS 19% YoY revenue growth in the quarter to $49.3M Raising full year revenue guidance to $180M - $182M Both metreleptin and lomitapide driving revenue...
AMRYT ANNOUNCES POSITIVE RESULTS FROM PHASE 3 TRIAL OF FILSUVEZ® IN EPIDERMOLYSIS BULLOSA
29 oct. 2020 03h00 HE
|
Amryt Pharma plc
AMRYT ANNOUNCES POSITIVE RESULTS FROM PHASE 3 TRIAL OF FILSUVEZ® IN EPIDERMOLYSIS BULLOSA LATE-BREAKING ORAL PRESENTATION AT THE 29TH EADV (VIRTUAL) CONGRESS ON OCTOBER 31 Virtual Analyst &...
Amryt and Swixx Sign Distribution Deal for Lojuxta
19 oct. 2020 02h00 HE
|
Amryt Pharma plc
AMRYT PHARMA PLC (“Amryt” or the “Company”) AMRYT AND SWIXX SIGN DISTRIBUTION DEAL FOR LOJUXTA® ACROSS 17 JURISDICTIONS IN CENTRAL AND EASTERN EUROPE (“CEE”) DUBLIN, Ireland, and Boston MA,...
Notice of Results
14 oct. 2020 02h00 HE
|
Amryt Pharma plc
AMRYT PHARMA PLC (“Amryt” or the “Company”) AMRYT TO ANNOUNCE Q3 RESULTS ON NOVEMBER 5, 2020 DUBLIN, Ireland, and Boston MA, October 14 2020, Amryt (Nasdaq: AMYT, AIM: AMYT), a global,...
Holding(s) in Company
12 oct. 2020 06h00 HE
|
Amryt Pharma plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
Virtual Analyst & Investor Event - Tuesday November 3, 2020
09 oct. 2020 02h00 HE
|
Amryt Pharma plc
AMRYT PHARMA PLC (“Amryt” or the “Company”) VIRTUAL ANALYST AND INVESTOR EVENT - TUESDAY NOVEMBER 3, 2020 - AMRYT TO PRESENT FULL DATA FROM EASE TRIAL AND LAUNCH PLANS FOR FILSUVEZ® AS A POTENTIAL...
AMRYT TO PRESENT EASE TRIAL DATA BY LATE-BREAKING PRESENTATION AT EADV ON OCTOBER 31, 2020
08 oct. 2020 02h00 HE
|
Amryt Pharma plc
AMRYT PHARMA PLC (“Amryt” or the “Company”) AMRYT TO PRESENT EASE TRIAL DATA BY LATE-BREAKING PRESENTATION AT EADV ON OCTOBER 31, 2020 DUBLIN, Ireland, and Boston MA, October 8 2020, Amryt...
Exercise of Options and Total Voting Rights
01 oct. 2020 02h00 HE
|
Amryt Pharma plc
AMRYT PHARMA PLC (“Amryt” or the “Company”) Exercise of Options and Total Voting Rights DUBLIN, Ireland, and Boston MA, October 1 2020, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...
Holding(s) in Company
30 sept. 2020 07h30 HE
|
Amryt Pharma plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
AMRYT SUPPORTS GLOBAL FH AWARENESS DAY – SEPTEMBER 24, 2020
23 sept. 2020 07h00 HE
|
Amryt Pharma Plc
AMRYT PHARMA PLC (“Amryt” or the “Company”) AMRYT SUPPORTS GLOBAL FH AWARENESS DAY – SEPTEMBER 24, 2020 DUBLIN, Ireland, and Boston MA, September 23 2020, Amryt (Nasdaq: AMYT, AIM: AMYT), a...